Incannex Healthcare (IXHL) Equity Income (2025 - 2026)

Incannex Healthcare's (IXHL) quarterly Equity Income came in at -$44000.0 in Q1 2026, down 500.0% quarter-over-quarter from $11000.0 in Q4 2025.

Analysis

Incannex Healthcare (IXHL) Equity Income (2025 - 2026) Analysis & Trends

Incannex Healthcare has disclosed Equity Income across 2 years of filings, most recently posting -$44000.0 for Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Income (Qtr)
1	Johnson & Johnson	643.50 Bn	622.74 Bn	17.26 Bn	-
2	AbbVie	440.29 Bn	433.72 Bn	12.70 Bn	-
3	Merck	364.93 Bn	357.79 Bn	12.21 Bn	-
4	Novartis Ag	266.65 Bn	258.96 Bn	11.24 Bn	-2.00 Mn
5	Pfizer	158.92 Bn	147.22 Bn	10.94 Bn	-
6	Sanofi	52.46 Bn	45.08 Bn	10.79 Bn	-10.46 Mn
7	Revolution Medicines	44.32 Bn	44.32 Bn	-	-
8	Incyte	25.32 Bn	20.78 Bn	1.57 Bn	-
9	United Therapeutics	21.42 Bn	18.75 Bn	683.80 Mn	-
10	Incannex Healthcare	41.43 Mn	41.43 Mn	-	-44,000.00

Historic Data

Download Data